GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer. - Test2 - elhamkhani - TriplyDB

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

http://www.wikidata.org/entity/Q35322421

about

The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer.DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis The role of epigenetics in genetic and environmental epidemiology.DNA methylation-based variation between human populations.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer.Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients Epigenetic risk score improves prostate cancer risk assessment.Epigenetic alterations in TRAMP mice: epigenome DNA methylation profiling using MeDIP-seq.Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.

P2860

Q26766285-3ACA46DA-80BE-4011-82F4-05EC6E6151C3 Q35163033-59227513-B175-44E4-8467-053FB49F1E07 Q35667011-E5ECAE59-778A-48F3-A755-0D57970A4EFA Q36150385-B558249D-AF54-499B-A94D-D34122419CD3 Q38617120-A2B1D289-2576-40FE-BA20-FCA78ED7B886 Q38798399-0A1DBDE4-7A1A-4B0B-83C4-EE750B7218A7 Q38833395-DB0B472F-CB04-4B74-BD24-384D3AE98FE8 Q40920100-17DCF62B-B9F6-4D4A-A997-61AAC39CA46D Q42314696-EE0257BC-625E-4218-BD06-E9926B986787 Q43152996-C1E63B60-57B9-4EF1-A239-F8B664A2407A Q49985254-1430EA15-C5BE-4F7E-9B0B-E8032F99D46B Q55004153-8C500A19-D637-45C3-A559-A3287043FB28

P2860

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

http://www.wikidata.org/entity/Q35322421

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

@ast

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

@en

type

label

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

@ast

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

@en

prefLabel

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

@ast

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

@en

P1433

Q35322421-0DEF68AF-74B6-413B-9006-7D2F8F847880

P1476

Q35322421-82952110-640C-4D72-B568-85C311A7E082

P2093

Q35322421-10B67D14-BB66-41C9-B0A2-514DD5AAC0B6

Q35322421-146E94F0-5035-44F8-84FC-F37B7751664C

Q35322421-3AF273F4-91A6-4D9D-8FB4-14E8DE5C2EB1

Q35322421-3BF3715E-2B00-49F3-AAF1-1FD32E12B561

Q35322421-641C46C1-E9F7-4979-BDE4-CCE23D63779A

Q35322421-6863CE2B-BFF4-40EA-B819-CBBAAAE89D6B

Q35322421-7877A502-6B3B-445F-A677-2BD09C88083D

Q35322421-88C2A5EE-DA36-454F-9095-AF39E571AC86

Q35322421-B0FEEE0C-B6DA-4359-A5E1-9D07D4E3112A

Q35322421-CAF54906-9B59-4517-BB08-4E5555AB2175

P2860

Q35322421-1163946D-DB5F-476D-9B21-55275FB7ADFA

Q35322421-1694CE86-5F83-4B0D-8D44-9B81239138CD

Q35322421-20CB9337-4DD3-45E4-9482-4D30EDF69E28

Q35322421-34BC14C3-C00D-463A-A7B5-F9A3CCDE48FE

Q35322421-35E5AA89-9160-4A4B-B00F-2BE41118FE50

Q35322421-5B8741F4-F317-47FA-9A5E-710E38A6D0BD

Q35322421-5CF36333-215D-44E8-9D75-2E28FF1DD69F

Q35322421-5F7C5534-51E8-407E-B95B-C2010F6E71C3

Q35322421-6B21FAE7-9EF7-4D83-8C0A-626860EF242F

Q35322421-77A5BD11-D323-4920-8A22-CB67CB32F3A3

P304

Q35322421-B42C6EDF-6A23-4F03-83CA-C3DF2CC10E71

P31

Q35322421-761891BD-D62C-46D5-814A-0C866A3CFA74

P356

Q35322421-2D5738AF-BE37-4707-BF65-6112D27FC72C

P407

Q35322421-247C097B-74C0-46E1-8B2E-C41EA878B4D9

P433

Q35322421-23792FA6-5B49-4959-8B56-65B144990177

P478

Q35322421-EBBA612F-1FC2-48C8-938B-C7E7F745531E

P50

Q35322421-0D13B29A-61BA-4206-B71E-9C82CC6808D9

Q35322421-FF0737C7-9DD9-4637-B62B-9793C29D97BF

P577

Q35322421-47955C0D-8B0B-4B44-B8B0-89FFFA12DFD8

P698

Q35322421-7A0EEFF9-940D-4750-994A-88272645C30A

P932

Q35322421-4BC9F3CF-D20D-4E6C-B36D-BDDF20694E12

P356

J.JURO.2014.04.082

P1433

The Journal of Urology

P1476

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

@en

P2093

Antoun Toubaji

http://www.w3.org/2001/XMLSchema#string

David Sidransky

http://www.w3.org/2001/XMLSchema#string

Eli Rosenbaum

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Platz

http://www.w3.org/2001/XMLSchema#string

George J Netto

http://www.w3.org/2001/XMLSchema#string

Kevin Wang

http://www.w3.org/2001/XMLSchema#string

Lauren Sullenberger

http://www.w3.org/2001/XMLSchema#string

Leonel Maldonado

http://www.w3.org/2001/XMLSchema#string

Myriam Loyo

http://www.w3.org/2001/XMLSchema#string

Roslyn Howard

http://www.w3.org/2001/XMLSchema#string

P2860

The fundamental role of epigenetic events in cancer

Gene silencing in cancer in association with promoter hypermethylation

Hypermethylation of genes for diagnosis and risk stratification of prostate cancer

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.

Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer

Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma.

AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy.

20-year outcomes following conservative management of clinically localized prostate cancer.

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

P304

1542-1548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2014.04.082

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

192

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad Obaidul Hoque

P577

2014-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24769028

http://www.w3.org/2001/XMLSchema#string

P932

4390043

http://www.w3.org/2001/XMLSchema#string